Literature DB >> 30215857

Immunobiology of Inherited Muscular Dystrophies.

James G Tidball1, Steven S Welc2, Michelle Wehling-Henricks3.   

Abstract

The immune response to acute muscle damage is important for normal repair. However, in chronic diseases such as many muscular dystrophies, the immune response can amplify pathology and play a major role in determining disease severity. Muscular dystrophies are inheritable diseases that vary tremendously in severity, but share the progressive loss of muscle mass and function that can be debilitating and lethal. Mutations in diverse genes cause muscular dystrophy, including genes that encode proteins that maintain membrane strength, participate in membrane repair, or are components of the extracellular matrix or the nuclear envelope. In this article, we explore the hypothesis that an important feature of many muscular dystrophies is an immune response adapted to acute, infrequent muscle damage that is misapplied in the context of chronic injury. We discuss the involvement of the immune system in the most common muscular dystrophy, Duchenne muscular dystrophy, and show that the immune system influences muscle death and fibrosis as disease progresses. We then present information on immune cell function in other muscular dystrophies and show that for many muscular dystrophies, release of cytosolic proteins into the extracellular space may provide an initial signal, leading to an immune response that is typically dominated by macrophages, neutrophils, helper T-lymphocytes, and cytotoxic T-lymphocytes. Although those features are similar in many muscular dystrophies, each muscular dystrophy shows distinguishing features in the magnitude and type of inflammatory response. These differences indicate that there are disease-specific immunomodulatory molecules that determine response to muscle cell damage caused by diverse genetic mutations. © 2018 American Physiological Society. Compr Physiol 8:1313-1356, 2018.
Copyright © 2018 American Physiological Society. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 30215857      PMCID: PMC7769418          DOI: 10.1002/cphy.c170052

Source DB:  PubMed          Journal:  Compr Physiol        ISSN: 2040-4603            Impact factor:   9.090


  373 in total

1.  Altered proteasome function and subunit composition in aged muscle.

Authors:  Aimee D Husom; Elizabeth A Peters; Erin A Kolling; Nicole A Fugere; LaDora V Thompson; Deborah A Ferrington
Journal:  Arch Biochem Biophys       Date:  2004-01-01       Impact factor: 4.013

2.  Evidence for a role of osteopontin in macrophage infiltration in response to pathological stimuli in vivo.

Authors:  C M Giachelli; D Lombardi; R J Johnson; C E Murry; M Almeida
Journal:  Am J Pathol       Date:  1998-02       Impact factor: 4.307

3.  Eosinophil-mediated killing of Haemonchus contortus larvae: effect of eosinophil activation and role of antibody, complement and interleukin-5.

Authors:  M A Rainbird; D Macmillan; E N Meeusen
Journal:  Parasite Immunol       Date:  1998-02       Impact factor: 2.280

4.  Role of thrombospondin 1 in macrophage inflammation in dysferlin myopathy.

Authors:  Noemí De Luna; Eduard Gallardo; Corinne Sonnet; Bénédicte Chazaud; Raúl Dominguez-Perles; Xavier Suarez-Calvet; Romain K Gherardi; Isabel Illa
Journal:  J Neuropathol Exp Neurol       Date:  2010-06       Impact factor: 3.685

5.  A pilot trial of prednisone in facioscapulohumeral muscular dystrophy. FSH-DY Group.

Authors:  R Tawil; M P McDermott; S Pandya; W King; J Kissel; J R Mendell; R C Griggs
Journal:  Neurology       Date:  1997-01       Impact factor: 9.910

6.  Osteopontin is highly expressed in severely dystrophic muscle and seems to play a role in muscle regeneration and fibrosis.

Authors:  Simona Zanotti; Sara Gibertini; Claudia Di Blasi; Cristina Cappelletti; Pia Bernasconi; Renato Mantegazza; Lucia Morandi; Marina Mora
Journal:  Histopathology       Date:  2011-12       Impact factor: 5.087

7.  Muscle injury activates resident fibro/adipogenic progenitors that facilitate myogenesis.

Authors:  Aaron W B Joe; Lin Yi; Anuradha Natarajan; Fabien Le Grand; Leslie So; Joy Wang; Michael A Rudnicki; Fabio M V Rossi
Journal:  Nat Cell Biol       Date:  2010-01-17       Impact factor: 28.824

8.  Reduced muscle necrosis and long-term benefits in dystrophic mdx mice after cV1q (blockade of TNF) treatment.

Authors:  Hannah G Radley; Marilyn J Davies; Miranda D Grounds
Journal:  Neuromuscul Disord       Date:  2008-01-22       Impact factor: 4.296

9.  Fibrinogen that appears in Bowman's space of proteinuric kidneys in vivo activates podocyte Toll-like receptors 2 and 4 in vitro.

Authors:  Masaru Motojima; Taiji Matsusaka; Valentina Kon; Iekuni Ichikawa
Journal:  Nephron Exp Nephrol       Date:  2009-11-03

10.  Dysferlinopathy course and sportive activity: clues for possible treatment.

Authors:  C Angelini; E Peterle; A Gaiani; L Bortolussi; C Borsato
Journal:  Acta Myol       Date:  2011-10
View more
  31 in total

1.  Proteomic profiling of the mouse diaphragm and refined mass spectrometric analysis of the dystrophic phenotype.

Authors:  Sandra Murphy; Margit Zweyer; Maren Raucamp; Michael Henry; Paula Meleady; Dieter Swandulla; Kay Ohlendieck
Journal:  J Muscle Res Cell Motil       Date:  2019-03-19       Impact factor: 2.698

2.  Mineralocorticoid receptor antagonists improve membrane integrity independent of muscle force in muscular dystrophy.

Authors:  J Spencer Hauck; Jeovanna Lowe; Neha Rastogi; Kevin E McElhanon; Jennifer M Petrosino; Kyra K Peczkowski; Ashlee N Chadwick; Jonathan G Zins; Federica Accornero; Paul M L Janssen; Noah L Weisleder; Jill A Rafael-Fortney
Journal:  Hum Mol Genet       Date:  2019-06-15       Impact factor: 6.150

3.  Antioxidant effects of bis-indole alkaloid indigo and related signaling pathways in the experimental model of Duchenne muscular dystrophy.

Authors:  Daniela Sayuri Mizobuti; Guilherme Luiz da Rocha; Heloina Nathalliê Mariano da Silva; Caroline Covatti; Caroline Caramano de Lourenço; Elaine Cristina Leite Pereira; Marcos José Salvador; Elaine Minatel
Journal:  Cell Stress Chaperones       Date:  2022-06-10       Impact factor: 3.827

4.  Identification of Auxiliary Biomarkers and Description of the Immune Microenvironmental Characteristics in Duchenne Muscular Dystrophy by Bioinformatical Analysis and Experiment.

Authors:  Xu Han; Jingzhe Han; Ning Wang; Guang Ji; Ruoyi Guo; Jing Li; Hongran Wu; Shaojuan Ma; Pingping Fang; Xueqin Song
Journal:  Front Neurosci       Date:  2022-06-03       Impact factor: 5.152

Review 5.  Mineralocorticoid Receptor Signaling in the Inflammatory Skeletal Muscle Microenvironments of Muscular Dystrophy and Acute Injury.

Authors:  Zachary M Howard; Chetan K Gomatam; Arden B Piepho; Jill A Rafael-Fortney
Journal:  Front Pharmacol       Date:  2022-06-28       Impact factor: 5.988

6.  Early Inflammation in Muscular Dystrophy Differs between Limb and Respiratory Muscles and Increases with Dystrophic Severity.

Authors:  Zachary M Howard; Jeovanna Lowe; Anton J Blatnik; Deztani Roberts; Arthur H M Burghes; Shyam S Bansal; Jill A Rafael-Fortney
Journal:  Am J Pathol       Date:  2021-01-23       Impact factor: 4.307

7.  Myeloid mineralocorticoid receptors contribute to skeletal muscle repair in muscular dystrophy and acute muscle injury.

Authors:  Zachary M Howard; Neha Rastogi; Jeovanna Lowe; J Spencer Hauck; Pratham Ingale; Chetan Gomatam; Celso E Gomez-Sanchez; Elise P Gomez-Sanchez; Shyam S Bansal; Jill A Rafael-Fortney
Journal:  Am J Physiol Cell Physiol       Date:  2022-01-19       Impact factor: 4.249

Review 8.  Histopathology of Duchenne muscular dystrophy in correlation with changes in proteomic biomarkers.

Authors:  Margit Zweyer; Hemmen Sabir; Paul Dowling; Stephen Gargan; Sandra Murphy; Dieter Swandulla; Kay Ohlendieck
Journal:  Histol Histopathol       Date:  2021-12-07       Impact factor: 2.303

Review 9.  Therapeutic aspects of cell signaling and communication in Duchenne muscular dystrophy.

Authors:  Alicja Starosta; Patryk Konieczny
Journal:  Cell Mol Life Sci       Date:  2021-04-07       Impact factor: 9.261

10.  Co-Transplantation of Bone Marrow-MSCs and Myogenic Stem/Progenitor Cells from Adult Donors Improves Muscle Function of Patients with Duchenne Muscular Dystrophy.

Authors:  Aleksandra Klimczak; Agnieszka Zimna; Agnieszka Malcher; Urszula Kozlowska; Katarzyna Futoma; Jaroslaw Czarnota; Pawel Kemnitz; Anna Bryl; Maciej Kurpisz
Journal:  Cells       Date:  2020-04-30       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.